Alan Baik is a Cardiology physician affiliated with Gladstone Institutes. OpenAlex indexes 37 publications with 1,000 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Baxter HealthcareProgram year20251 payment
- Kiniksa Pharmaceuticals International, plcProgram year20241 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.2%Beta blocker22.7%Metoprolol Succinate60%Carvedilol31%Metoprolol Tartrate9%Part D<11 patientsStatin14.1%Atorvastatin Calcium54%Rosuvastatin Calcium46%Part D≥16 patients+ 6 more classes in this area
Metabolism & gastrointestinal
12%SGLT2 inhibitor9.1%Jardiance100%Part D≥18 patientsPotassium supplement2.9%Potassium Chloride100%Part D<11 patientsCancer & immunology
2.9%Interleukin inhibitors2.9%Arcalyst100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- SREBP1 as a Novel Mammalian Oxygen Sensor
University of California, San Francisco
FY2026$162,922K08HL169915 - SREBP1 as a Novel Mammalian Oxygen Sensor
University of California, San Francisco
FY2025$162,946K08HL169915 - SREBP1 as a Novel Mammalian Oxygen Sensor
University of California, San Francisco
FY2024$162,972K08HL169915
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Genome-wide CRISPRi screen identifies basigin loss as protective in cardiac hypoxia
bioRxiv (Cold Spring Harbor Laboratory)
2026 - Hyperoxia reflects poor native cardiac function and demonstrates cardiac index-dependent associations with mortality in veno-arterial extracorporeal membrane oxygenation patients
European Heart Journal Acute Cardiovascular Care
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Lennart Mucke, MD
Gladstone Institutes
Alexander Marson, MD, PhD
Gladstone Institutes
Ken Nakamura
Gladstone Institutes
Peter Sohn, MD
Gladstone Institutes
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Gregg Fonarow, MD
Ronald Reagan UCLA Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”